Clinical Immunology Service
Organisational unit: Department
Research Projects
Defining the usefulness of high CD34+CD38low blast frequency in blood of adult AML patients - a pre-treatment biomarker of poor outcome to standard chemotherapy
BLOODWISE
1/04/16 → 31/05/20
Project: Research
Characterisation of the immune sequelae of post-transplant azacitidine and lenalidomide in patients with relapsed AML
Charles Craddock, Manoj Raghavan & Sylvie Freeman
BLOODWISE
1/10/15 → 30/09/17
Project: Research
Preclinical testing of low dose valproate and niclosamide (VaN) as novel anti-myeloma therapy
BLOODWISE
1/09/15 → 30/04/18
Project: Research
Integrating innovative technologies for genotyping in stratified medicine
Paul Moss, Warwick Dunn, Andrew Beggs, Mark Viant, Mark Drayson, David Adams, Conny Bonifer & Ulrich Guenther
MEDICAL RESEARCH COUNCIL
1/04/15 → 1/07/18
Project: Research Councils
Evaluating the Role of Minimal Residual Disease Monitoring in Predicting Outcome After Reduced Intensity Allografts in AML
Charles Craddock, Sylvie Freeman, Manoj Raghavan & Keith Wheatley
BLOODWISE
1/02/15 → 31/01/18
Project: Research
Exploring the effect of exercise on immune function and beta cell health in patients with type 1 diabetes
Parth Narendran, John Campbell & Mark Drayson
UHB NHS TRUST
1/10/14 → 30/09/18
Project: Research
Optimising Renal outcome in Myeloma renal failure
OXFORD UNIVERSITY HOSPITALS NHS TRUST
1/08/14 → 31/12/19
Project: Research
Modernising and Improving the identification and management of plasma cell cancers
SERASCIENCE LTD
13/02/14 → 12/02/16
Project: Industry
Specialst Programme : Aldo-keto reductases (AKRs), BaP Therapgy and drug redeployment strategies for accelerating thraphy development for haematological cancers
BLOODWISE
1/10/13 → 31/12/19
Project: Research
Redirected Viral Immunotherapy for Acute Myeloid Leukaemia
Mark Cobbold, Sylvie Freeman, Pamela Kearns & Victoria Weston
BLOODWISE
9/09/13 → 8/09/16
Project: Research